is the statement below supposed to be

New Post Public Reply Private Reply Replies (1) Message Board
thesmalls CountryMac #10453
is the statement below supposed to be constructive...?

"Lol so what financial model would you like them to setup with little to no historical data and a brand new business plan that hasnt even been finalized yet?"

well - for starters - they could reference the 6/15 business plan which was a more detailed, updated version of the 3/14 business plan. they could start with the numbers below taken from the 6/15 plan:

2. The Company is sole source to China, with price points a minimum of 24% less than what a
and MROs are paying now, and low cost to the global market
3. The Company dramatically changes global marketplace by reducing delivery
times
approximately 32-­‐52 weeks to as little as 30 days







Pro Forma Income Statement ($m) Year 1 Year 2 Year 3 Year 4 Year
5 Revenue ($m) $4.20 $25.40 $67
$106 $149 Direct Labor Cost ($m) $0.30 $1.50
$4 $6 $9 Material Cost ($m)
$0.40 $2.30 $6 $9 $13 Production Overhead $m)
$0.80 $4.60 $12 $19 $27 Gross Profit
($m) $2.80 $17.00 $45 $71
$100 Costs of Sales (% of Revenue) 25% 25% 25%
25% 25% Costs of Sales ($m) $1.10
$6.30 $17 $26 $37 Corporate Overhead (% of Revenue) 30%
30% 20% 15% 10% Corporate Overhead ($m)
$1.3 $7.60 $13 $16 $15 Profit Before Tax ($m)
$0.50 $3.10 $15 $29 $48 Profit %
of Revenue 12% 12% 22% 27%
32%

Again - these are taken straight from their 6/15 business plan. those are some rather detailed projections with "little to no historical data." those were provided/updated when revenue operations hadnt even begun nor were expected to for another 6 months. revenue operations HAVE begun and should be expanding. so - relative to the original 5 year plan above which have Y1 revenues at $4.2MM and Y5 at $149MM - is the current outlook better or worse...? why is that such a difficult question? more importantly - why isnt every long term investor asking the same thing?

have you looked at the current overhead on a quarterly basis and the costs for SG&A? either they are producing revenues now that havent been announced, have arranged financing that hasnt been 8Kd, or will be diluting with stock sales to fund operations. per the last quarter - they would have gone insolvent within weeks of the report being due. obviously that isnt the case. so - how are they funding operations?

as far as the pictures of the plant - i didnt say the company was perpetuating a fraud. in the absence of concrete numbers, lack of cash, OS going from 1.8 to 3.5, and a rather argumentative and obtuse IR stream - it could be construed as such. i have seen OTC companies do trial runs, create a marketing stir, pump the hell out of the company and then ride off into the sunset while investors were left wondering what the hell happened. TBEV is a good, recent example. two R/s in 12 months and the price went right back down to 0.0001 within a month or so each time only to have another round of debt financing and grandiose promises from mgmt. never would mgmt EVER commit to any type of revenue stream.

now - i am NOT saying TPAC is in any way illegitimate. if i thought that (or ever start to think it), i wont be sticking around holding shares "hoping" i am wrong. further, it is much different spending $15-20K on a production run and hyping sales then spending $2-4MM on NAVAIR certification when competitors havent been able to achieve that level spending $10MM+ and over 12 years in R&D (per Bill's shareholder letter 7/15). mgmt/insiders would have to turn over a LOT of stock to payback that investment.

the disconnect is where the company is from a straightforward approach with investors back in 2014-2015 to where they are now. they were confident enough back 18 months ago to publish this revenue stream, talk about stock buybacks, and M&A. why can they not even commit to WHEN they will update investors on how current operating environment/restructuring has materially affected their outlook relative to just over a year ago? please - enlighten me. where is the rationale for keeping investors "waiting"...? while we wait, the PPS is getting taken advantage of and there continues to be dilution. while it may have been a small amount on a %basis to OS - it was STILL 70-80 MM shares and the price is within ticks of where it was trading a year ago at this time. that is against their commitment to maintaining and increasing shareholder value.

i have been impressed with Bill's commitment and straightforward approach in past calls, presentations, and Q&A. however, since IR has taken over - the communication has gone sideways and obfuscation seems to be the new "norm." back in the 7/15 CC - Bill routinely noted that this was a long process and not a "get rich quick" type of investment. he said it was going to be a long road but a lot of the heavy lifting had already been accomplished. he was very conservative and (again) straightforward with how they would ramp up those revenues on the 5 year plan (back then it was heavy on the M&A which would be financed by the Hong Kong backers based on existing acquisition target revenue streams and ability to dramatically accelerate based on $TPAC s certification and China based operations giving them cost advantage via offsets). so - why now is he so reticent to even give a timeframe on when he WILL update/discuss?

so - i would like them to stick with the financial model provided to investors last summer and update it to reflect new business structure and market environment (heavy on the SLAs vs acquisition relative to revenue expansion). start with revenue stream and then discuss how the SLA agreements affect material costs, production overhead, and ultimately GP per part which will ultimately determine how quickly they become profitable. since they had this level of detail and confidence over a year ago (longer when one assumes how long it took to prepare the plan and vet it prior to release) - i would think they would have a higher level of confidence now in the success even if the rate of expansion (or revenues/profits) may be more in question due to the nature of the SLAs.

i certainly do not think that is too much to ask for and the notion that i (or others) are "bashers" for questioning IR's commitment to such is absurd. this is absolutely, fundamental DD and the burden of legitimacy is squarely on the company until results prove prior commitments. it may be "unfair" but that is the nature of the OTC. besides, it is certainly in line with what analysts ask/question in any blue chip CC of quarterly results (top and bottom line growth or lack thereof and how costs and overhead materially impacted gross/net profit).

so - lets keep the board constructive and debate the pros and cons and drive unanswered questions through IR/company rather than suggest that these questions are being subtly answered via tweets or that the numbers can be gleamed from such if one looks deeper. right now - NONE of the announcements have been concrete. a lot of potential but nothing that one can pin specific numbers to and really compare market capitalization to fair market value in the PPS.

if anyone is interested in discussion and delving into this - i am more than inclined. if the remarks are going to be snide or pie in the sky cheerleading - i am not interested. OS is going up, PPS has been going down (though it looks like it has bottomed and ready to reverse), and the company still has not committed/recommitted to growth plans laid out in 2014 and 2015.

to me - that doesnt make sense.


Trans-Pacific Aerospace (TPAC) Stock Research Links

TPAC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

TilePix Expands into Walmart with Nail-Free Decor Launch

Updated Category News Views 0

TilePix Makes Big Moves with Walmart TilePix is launching their new line of nail-free wall décor at Walmart—this ain’t your grandma’s wall art. This company's bringing their magnetic, nail-free wizardry to retail stores nationwide for the first time, and they’ve chosen a real heavyweight partner—Walmart. What comes in the package? Well, they’re dealing in...

Continue Reading
AI-Designed Antivirals: A Brave New World

Updated Category News Views 4

Pushing the Boundaries with AI in Drug Discovery It seems some smart folks over in South Korea are giving the pharma game a fresh twist, pitting artificial intelligence against viral invaders in a newfangled brawl. Professors from Korea University have managed to blend AI's computing prowess with good ol' lab doggedness to sniff out potential antiviral compounds. The...

Continue Reading
Ama La Vida's New Coaching: More Than a Financial Plan

Updated Category News Views 2

Breaking the Retirement Myth Retirement ain't just about sailing off into the sunset with a fat wallet. What happens when the honeymoon period of the "golden years" ends and you're left pacing the floorboards, unsure of what comes next? Enter Ama La Vida's fresh approach to retirement coaching, tackling the side of retirement that's rarely spoken about: identity,...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 35

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Costa Rican Firms Chase Growth at SIAL Paris 2026

Updated Category News Views 0

Chasing Growth in Paris: Costa Rica's Bold Move When it comes to playing the global field, Costa Rica isn't just sitting back; they're on the move. Picture this: PROCOMER, along with 18 standout companies, landed smack dab in the grand hustle and bustle of SIAL Paris 2026. This isn't some leisurely stroll—it's a calculated sprint toward expanding their reach across...

Continue Reading
Noé Hinojosa Jr. Honored for Leadership in Business

Updated Category News Views 1

From Bonds to Ballgames: Hinojosa's Impact Listen up, because this one’s more than just another accolade on a shelf. Noé Hinojosa Jr., a big gun over at TRB Securities, is getting the 2026 Hispanic Business Salute Award, and it's a doozy. Awarded by all the big wigs—UPS, NBC 5, Telemundo 39, and the Dallas Cowboys—this isn't a small pat on the back. It's a full-on...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 46

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 50

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Clean Power Alliance's Bond Deal Secures $91M Savings

Updated Category News Views 0

CPA Triumphs Yet Again With Bond Savings I'll tell you, the Clean Power Alliance (CPA) just hit the jackpot again. We're talking a $1.4 billion energy prepayment bond deal that locks in a whopping $91.1 million in savings over the next seven years. Not bad, huh? A Closer Look at the Numbers CPA's charm—besides being the top green power supplier in the U.S.—is spinning...

Continue Reading
Match2 Enhances HR Tech: Unified Talent Profile System

Updated Category News Views 7

Revolutionizing Talent Matching with Match2's Latest Upgrades In the churn of today's recruiting jungle, candidates and employers have been grappling with disjointed systems and outdated approaches. Well, Match2 is cutting through that noise with some hefty upgrades. It's got some new toys in the shed—specifically, a beefed-up Universal Candidate Profile™ and an...

Continue Reading

Top 5 Most Recently Viewed Articles

First Trust Mortgage Income Fund Announces Monthly Dividend

Updated Category News Views 43

First Trust Mortgage Income Fund's Monthly Distribution Announcement First Trust Mortgage Income Fund (NYSE: FMY) has declared its upcoming monthly common share distribution, marking an important date for its shareholders. The distribution set at $0.075 per share is payable soon, showing the Fund's commitment to providing consistent returns. Details About the Distribution...

Continue Reading
Akeso's 2024 Annual Report: Innovations in Bispecific Therapies

Updated Category News Views 718

Revolutionizing Cancer Treatment Through Innovation Akeso Inc. has announced its annual results for 2024, showcasing major achievements in biotechnology innovation. The company has focused on developing cutting-edge therapies, particularly in bispecific antibodies, aimed at transforming the treatment landscape for various cancers. Key Accolades and Advancements Key...

Continue Reading
Rona Therapeutics Receives Approval for RN1871 siRNA Treatment

Updated Category News Views 395

Rona Therapeutics Makes Significant Strides in Hypertension Treatment Rona Therapeutics, a biotechnology leader in RNA-targeted therapies, has achieved an impressive milestone with the approval of its Investigational New Drug (IND) application for RN1871 by China's National Medical Products Administration (NMPA). This innovative small interfering RNA (siRNA) drug is...

Continue Reading
Fleet Management Market Growth Forecast of USD 52.23 Billion

Updated Category News Views 150

Understanding Fleet Management Market Evolution The global fleet management market is poised for significant growth, expected to expand by USD 52.23 billion between 2025 and 2029. This growth is primarily fueled by the surge in e-commerce and the pressing need for last-mile delivery solutions. As industries continue to evolve, the integration of technology is transforming...

Continue Reading
Projected Growth and Challenges in the Anisole Market by 2033

Updated Category News Views 105

Understanding the Global Anisole Market Trends The global anisole market has been on a robust growth trajectory. Valued at approximately US$ 98.78 million as of recent estimates, it is poised to reach a remarkable US$ 165.48 million by 2033, with a compound annual growth rate (CAGR) of 5.9% from 2025 onwards. This upward trend indicates a significant demand for anisole...

Continue Reading